(CN) - The Federal Circuit upheld an order blocking Apotex from making and selling a generic version of AstraZeneca's Pulmicort Respules, a prescription asthma treatment for children. Each "respule" ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback